These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25448490)
1. Effective treatment against severe graft-versus-host disease with allele-specific anti-HLA monoclonal antibody in a humanized mouse model. Nakauchi Y; Yamazaki S; Napier SC; Usui J; Ota Y; Takahashi S; Watanabe N; Nakauchi H Exp Hematol; 2015 Feb; 43(2):79-88.e1-4. PubMed ID: 25448490 [TBL] [Abstract][Full Text] [Related]
2. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia. Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532 [TBL] [Abstract][Full Text] [Related]
3. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice. Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121 [TBL] [Abstract][Full Text] [Related]
4. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells]. Gao L; Wang JM; Xie LN; Zhou H; Qiu HY Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):87-91. PubMed ID: 18681307 [TBL] [Abstract][Full Text] [Related]
5. Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice. Ehx G; Somja J; Warnatz HJ; Ritacco C; Hannon M; Delens L; Fransolet G; Delvenne P; Muller J; Beguin Y; Lehrach H; Belle L; Humblet-Baron S; Baron F Front Immunol; 2018; 9():1943. PubMed ID: 30214443 [TBL] [Abstract][Full Text] [Related]
6. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood. Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099 [TBL] [Abstract][Full Text] [Related]
7. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Bruck F; Belle L; Lechanteur C; de Leval L; Hannon M; Dubois S; Castermans E; Humblet-Baron S; Rahmouni S; Beguin Y; Briquet A; Baron F Cytotherapy; 2013 Mar; 15(3):267-79. PubMed ID: 23265769 [TBL] [Abstract][Full Text] [Related]
8. Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg(-/-) (NSG) Mice. Gregoire-Gauthier J; Fontaine F; Benchimol L; Nicoletti S; Selleri S; Dieng MM; Haddad E Biol Blood Marrow Transplant; 2015 May; 21(5):821-8. PubMed ID: 25596424 [TBL] [Abstract][Full Text] [Related]
9. Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation. Fujii H; Luo ZJ; Kim HJ; Newbigging S; Gassas A; Keating A; Egeler RM PLoS One; 2015; 10(7):e0133216. PubMed ID: 26176698 [TBL] [Abstract][Full Text] [Related]
10. Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-γc-/- mouse model. Hogenes MC; van Dorp S; van Kuik J; Monteiro FR; ter Hoeve N; van Dijk MR; Martens AC; de Weger RA Biol Blood Marrow Transplant; 2012 Jul; 18(7):1023-35. PubMed ID: 22579931 [TBL] [Abstract][Full Text] [Related]
11. Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab. Chen X; Chang CH; Stein R; Cardillo TM; Gold DV; Goldenberg DM Biol Blood Marrow Transplant; 2013 Jan; 19(1):28-39. PubMed ID: 23025988 [TBL] [Abstract][Full Text] [Related]
13. Modeling Human Graft-Versus-Host Disease in Immunocompromised Mice. Norelli M; Camisa B; Bondanza A Methods Mol Biol; 2016; 1393():127-32. PubMed ID: 27033222 [TBL] [Abstract][Full Text] [Related]
14. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956 [TBL] [Abstract][Full Text] [Related]
15. Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease. Amir AL; Hagedoorn RS; van Luxemburg-Heijs SA; Marijt EW; Kruisselbrink AB; Frederik Falkenburg JH; Heemskerk MH Biol Blood Marrow Transplant; 2012 Feb; 18(2):210-9. PubMed ID: 22015995 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells. Hilger N; Glaser J; Müller C; Halbich C; Müller A; Schwertassek U; Lehmann J; Ruschpler P; Lange F; Boldt A; Stahl L; Sack U; Oelkrug C; Emmrich F; Fricke S Cytometry A; 2016 Sep; 89(9):803-15. PubMed ID: 27560708 [TBL] [Abstract][Full Text] [Related]
17. Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice. Hu Y; Gu Y; Cui Q; Fu H; Sheng L; Wu K; Liu L; Fu S; Yu X; Huang H Ann Hematol; 2012 Nov; 91(11):1803-12. PubMed ID: 22699803 [TBL] [Abstract][Full Text] [Related]